| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |